PCVX SG&A Expenses

Vaxcyte Inc · SG&A Expenses

PCVX logo

PCVX SG&A Expenses

Latest reported$132.67M
PCVX SG&A Expenses ($5.05M → $132.67M)
High-resolution chart · PNG

PCVX sg&a expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vaxcyte Inc SG&A Expenses — Annual fiscal periods (USD)
Period endingSG&A Expenses (USD)
129,369,000
92,902,000
60,700,000
39,810,000
25,259,000
14,612,000
7,314,000
5,388,000
5,048,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.